CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo
Handong Dan, Xinlan Lei, Xin Huang, Ning Ma, Yiqiao Xing, Yin Shen
Topics & Concepts
AngiogenesisNeovascularizationUmbilical veinVascular endothelial growth factorKinase insert domain receptorTyrosine kinaseIn vivoCancer researchVasculogenesisCell biologyVascular endothelial growth factor AIn vitroChemistryEndothelial stem cellPharmacologyBiologySignal transductionBiochemistryVEGF receptorsBiotechnologyRetinal Diseases and TreatmentsAngiogenesis and VEGF in CancerGlaucoma and retinal disorders